Literature DB >> 8967783

Phospholipase A2 is secreted by murine keratinocytes after stimulation with IL-1 alpha and TNF-alpha.

B C Bastian1, R J Schacht, E Kämpgen, E B Bröcker.   

Abstract

Phospholipase A2 (PLA2)-catalysed liberation of arachidonic acid is the rate-limiting step in the generation of the lipid mediators prostaglandins and leukotrienes. PLA2 regulation thus represents a pivotal mechanism in the pathogenesis of inflammation. In this study we investigated the effects of TNF alpha and IL-1 alpha on PLA2 activity in cultured murine keratinocytes. Starting 18 h after stimulation, PLA2 activity increased significantly by about 250-320%) in the supernatants and in the cell pellets. This effect was completely inhibited either by preincubation of the cells with dexamethasone 48 h before stimulation or by coincubation with actinomycin D. PLA2 activity detected in the supernatants was blocked by reduction with dithiothreitol, whereas the PLA2 activity in the pellets was dithiothreitol-resistant. We conclude that in murine keratinocytes IL-1 alpha induce de novo synthesis and release of a secretory PLA2 and the induction of a different PLA2 activity in the cytosol. These findings indicate a crucial link between early cytokine effects and the initiation of the lipid mediator cascade in keratinocytes. The observation that PLA2 induction could be completely inhibited by preincubation with dexamethasone allows new insights into the mechanism of steroid effects on epidermal inflammation and renders PLA2 regulation an interesting therapeutic target.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8967783     DOI: 10.1007/bf02505824

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  48 in total

1.  Purification and characterization of rabbit platelet cytosolic phospholipase A2.

Authors:  D K Kim; I Kudo; K Inoue
Journal:  Biochim Biophys Acta       Date:  1991-04-24

2.  Epidermal growth factor enhances glomerular mesangial cell soluble phospholipase A2 activity.

Authors:  J V Bonventre; J H Gronich; R A Nemenoff
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

3.  A unique phospholipase A2 in human epidermis: its physiologic function and its level in certain dermatoses.

Authors:  M Bergers; D R Verhagen; M Jongerius; P C van de Kerkhof; P D Mier
Journal:  J Invest Dermatol       Date:  1988-01       Impact factor: 8.551

4.  Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent.

Authors:  A J Aarsman; G Mynbeek; H van den Bosch; B Rothhut; B Prieur; C Comera; L Jordan; F Russo-Marie
Journal:  FEBS Lett       Date:  1987-07-13       Impact factor: 4.124

Review 5.  Role of secretory phospholipases A2 in the pathobiology of disease.

Authors:  P Vadas; W Pruzanski
Journal:  Lab Invest       Date:  1986-10       Impact factor: 5.662

6.  Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid.

Authors:  L L Lin; A Y Lin; J L Knopf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

7.  Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor.

Authors:  D R Spriggs; M L Sherman; K Imamura; M Mohri; C Rodriguez; G Robbins; D W Kufe
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

8.  Arachidonic acid metabolism in cultured mouse keratinocytes.

Authors:  H Kondoh; Y Sato; H Kanoh
Journal:  J Invest Dermatol       Date:  1985-07       Impact factor: 8.551

9.  Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7.

Authors:  C C Leslie; D R Voelker; J Y Channon; M M Wall; P T Zelarney
Journal:  Biochim Biophys Acta       Date:  1988-12-16

10.  Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis.

Authors:  W G Hoeck; C S Ramesha; D J Chang; N Fan; R A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.